Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.66 |
| ▸ | NPC1 | O15118 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.66 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.66 |
| ▸ | RELA | Q04206 | 2/20 | 0.66 |
| ▸ | GAA | P10253 | 2/20 | 0.66 |
| ▸ | GFER | P55789 | 2/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.66 |
| ▸ | MITF | O75030 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.66 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4680538 | 0.98 | RAB9A (0.64) | RAB9ANPC1ALDH1A1KDM4EMAPT | |
| Bromide SCHEMBL10947640 | 0.98 | RAB9A (0.64) | RAB9ANPC1ALDH1A1KDM4EMAPT | |
| SCHEMBL6985206 | 0.86 | NPC1 (0.68) | RAB9ANPC1ALDH1A1KDM4EMAPT | |
| SCHEMBL30563626 | 0.86 | RAB9A (0.61) | RAB9ANPC1ALDH1A1KDM4EMAPT | |
| SCHEMBL3113684 | 0.86 | RAB9A (0.61) | RAB9ANPC1ALDH1A1KDM4EMAPT | |
| SCHEMBL27549467 | 0.85 | RAB9A (0.59) | RAB9ANPC1ALDH1A1KDM4EMAPT | |
| SCHEMBL1638828 | 0.85 | RAB9A (0.59) | RAB9ANPC1ALDH1A1KDM4EMAPT | |
| SCHEMBL7759315 | 0.84 | LMNA (0.67) | RAB9ANPC1ALDH1A1KDM4EMAPT | |
| Hydrochloric Acid SCHEMBL10757074 | 0.83 | RAB9A (0.58) | RAB9ANPC1ALDH1A1KDM4EMAPT | |
| SCHEMBL8243666 | 0.83 | HTT (0.59) | RAB9ANPC1ALDH1A1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117924682-B | Preparation method of aging-resistant polylactic acid material and aging-resistant polylactic acid material | 深圳市久信达科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-118459797-A | Aging-resistant toughening biodegradable master batch and film, and preparation and application thereof | 新疆蓝山屯河科技股份有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-117924682-A | Preparation method of aging-resistant polylactic acid material and aging-resistant polylactic acid material | 深圳市久信达科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-117683240-A | Method for preparing iron-based MOFs by electron beam irradiation, iron-based MOFs and application | 上海大学 | 2024-03-12 | — | — | CN | claimed |
| CN-117343540-A | High dielectric constant thermotropic liquid crystal polymer composition and preparation method thereof | 宁波聚嘉新材料科技有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-114960229-A | Tent cloth dyeing process | 圣山集团有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-107910387-A | A kind of wide spectrum solar energy materials and preparation method thereof | 叶芳 | 2018-04-13 | — | — | CN | claimed |
| CN-101309922-A | Amino-aza-adamantane derivatives and methods of use | ABBOTT LAB (US) | 2008-11-19 | — | — | CN | claimed |
| EP-1926731-A2 | AMINO-AZA-ADAMANTANE DERIVATIVES AND METHODS OF USE | ABBOTT LABORATORIES (US) | 2008-06-04 | — | — | EP | claimed |
| WO-2007038058-A2 | AMINO-AZA-ADAMANTANE DERIVATIVES AND METHODS OF USE | ABBOTT LABORATORIES (US) | 2007-04-05 | — | — | WO | claimed |
| US-20070072892-A1 | Amino-aza-adamantane derivatives and methods of use | ABBOTT LABORATORIES | 2007-03-29 | — | — | US | claimed |
| US-7109243-B2 | Inhibitors of cathepsin S | IRM LLC (BM) | 2006-09-19 | — | — | US | claimed |
| WO-2026043617-A1 | COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF HEALTH CONDITIONS AND DRUG SCREENING | REGLAGENE, INC. (US) | 2026-02-26 | — | — | WO | disclosed |
| CN-120078779-A | Composition for inhibiting herpesvirus | 威斯康星州医药大学股份有限公司 | 2025-06-03 | — | — | CN | disclosed |
| US-20250115608-A1 | HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS | ARDELYX, INC. (US) | 2025-04-10 | — | — | US | disclosed |
| CN-117924682-B | Preparation method of aging-resistant polylactic acid material and aging-resistant polylactic acid material | 深圳市久信达科技有限公司 | 2025-03-25 | — | — | CN | disclosed |
| US-4505840-A | Heterocyclic electroactive polymers | CHEVRON RESEARCH COMPANY (US) | 1985-03-19 | — | — | US | disclosed |
| US-4263207-A | ANTIALLERGENS | MERCK & CO., INC. (US) | 1981-04-21 | — | — | US | disclosed |
| US-4041024-A | FOR POLYAMIDES AND POLYURETHANES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-08-09 | — | — | US | disclosed |
| US-4013632-A | SYNTHETIC FIBERS | PRODUITS CHIMIQUES UGINE KUHLMANN (FR) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070072892-A1 | Amino-aza-adamantane derivatives and methods of use | CHRNA7, CHRNA5, CHRNA1 | RAB9A 908/4885NPC1 1243/4885ALDH1A1 1034/4885 |
| US-20250115608-A1 | HORMONE RECEPTOR MODULATORS FOR TREATING METABOLIC CONDITIONS AND DISORDERS | NR1H4, FXR1, GLP1R | RAB9A 1557/4885NPC1 1178/4885ALDH1A1 2057/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.